CN117355503A - Kv7通道开放剂的前药 - Google Patents
Kv7通道开放剂的前药 Download PDFInfo
- Publication number
- CN117355503A CN117355503A CN202280034761.1A CN202280034761A CN117355503A CN 117355503 A CN117355503 A CN 117355503A CN 202280034761 A CN202280034761 A CN 202280034761A CN 117355503 A CN117355503 A CN 117355503A
- Authority
- CN
- China
- Prior art keywords
- disorders
- depression
- disease
- dyskinesia
- dystonia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163163470P | 2021-03-19 | 2021-03-19 | |
| US63/163,470 | 2021-03-19 | ||
| PCT/US2022/021058 WO2022198115A1 (en) | 2021-03-19 | 2022-03-20 | Prodrugs of kv7 channel openers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117355503A true CN117355503A (zh) | 2024-01-05 |
Family
ID=83321210
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280034761.1A Pending CN117355503A (zh) | 2021-03-19 | 2022-03-20 | Kv7通道开放剂的前药 |
| CN202280034079.2A Pending CN117295711A (zh) | 2021-03-19 | 2022-03-20 | Kv7通道开放剂的前药 |
| CN202280034756.0A Pending CN117321031A (zh) | 2021-03-19 | 2022-03-20 | Kv7通道开放剂的前药 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280034079.2A Pending CN117295711A (zh) | 2021-03-19 | 2022-03-20 | Kv7通道开放剂的前药 |
| CN202280034756.0A Pending CN117321031A (zh) | 2021-03-19 | 2022-03-20 | Kv7通道开放剂的前药 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20240208896A1 (enExample) |
| EP (3) | EP4308544A4 (enExample) |
| JP (2) | JP2024511057A (enExample) |
| KR (2) | KR20230159531A (enExample) |
| CN (3) | CN117355503A (enExample) |
| AU (3) | AU2022240779A1 (enExample) |
| BR (2) | BR112023019074A2 (enExample) |
| CA (3) | CA3214270A1 (enExample) |
| IL (2) | IL306004A (enExample) |
| MX (2) | MX2023010978A (enExample) |
| WO (3) | WO2022198114A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115364229B (zh) * | 2022-09-26 | 2024-02-20 | 江苏海洋大学 | 一种用于预防或治疗疼痛的药物组合物 |
| CN118553447B (zh) * | 2024-07-30 | 2024-11-08 | 四川大学华西医院 | 动态惊恐障碍治疗方案推荐系统、治疗系统及存储介质 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5384330A (en) * | 1992-01-08 | 1995-01-24 | Asta Medica Aktiengesellschaft | Pharmaceutically active 1,2,4-triamino-benzene derivatives, processes for their preparation and pharmaceutical compositions containing them |
| US20060004197A1 (en) * | 2004-07-02 | 2006-01-05 | Thomas Thrash | Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| CN102159535A (zh) * | 2008-07-22 | 2011-08-17 | 特拉维夫大学拉莫特有限公司 | 钾离子通道调节剂及其用途 |
| CN103073455A (zh) * | 2011-10-25 | 2013-05-01 | 中国科学院上海药物研究所 | 一类新型的kcnq钾通道激动剂、其制备方法和用途 |
| WO2016077724A1 (en) * | 2014-11-13 | 2016-05-19 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | (2-amino-4(arylamino)phenyl) carbamates |
| CN109641836A (zh) * | 2016-06-10 | 2019-04-16 | 赛弗卢尔生命科学公司 | 氟化的2-氨基-4-(取代的氨基)苯基氨基甲酸酯衍生物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004115450A (ja) * | 2002-09-27 | 2004-04-15 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| US20090118285A1 (en) | 2006-02-07 | 2009-05-07 | H. Lundbeck A/S | Use of kcnq-openers for treating or reducing the symptoms of schizophrenia |
| EA201170230A1 (ru) | 2008-07-18 | 2011-08-30 | Вэлиант Фармасьютикалс Интернешнл | Препарат с модифицированной кинетикой высвобождения и способы его использования |
| WO2013179298A2 (en) * | 2012-04-23 | 2013-12-05 | Cadila Healthcare Limited | A process for preparation of phenyl carbamate derivative and polymorphic forms thereof |
| AU2019335070A1 (en) * | 2018-09-06 | 2021-05-13 | Ian Cooke | Method of treating a sleep breathing disorder |
-
2022
- 2022-03-20 EP EP22772332.7A patent/EP4308544A4/en active Pending
- 2022-03-20 KR KR1020237035814A patent/KR20230159531A/ko active Pending
- 2022-03-20 JP JP2023557407A patent/JP2024511057A/ja active Pending
- 2022-03-20 US US18/282,943 patent/US20240208896A1/en active Pending
- 2022-03-20 US US18/282,940 patent/US20240228434A1/en active Pending
- 2022-03-20 BR BR112023019074A patent/BR112023019074A2/pt unknown
- 2022-03-20 CN CN202280034761.1A patent/CN117355503A/zh active Pending
- 2022-03-20 WO PCT/US2022/021057 patent/WO2022198114A1/en not_active Ceased
- 2022-03-20 CN CN202280034079.2A patent/CN117295711A/zh active Pending
- 2022-03-20 IL IL306004A patent/IL306004A/en unknown
- 2022-03-20 IL IL306005A patent/IL306005A/en unknown
- 2022-03-20 WO PCT/US2022/021059 patent/WO2022198116A1/en not_active Ceased
- 2022-03-20 EP EP22772331.9A patent/EP4308543A4/en active Pending
- 2022-03-20 AU AU2022240779A patent/AU2022240779A1/en active Pending
- 2022-03-20 KR KR1020237035629A patent/KR20230159506A/ko active Pending
- 2022-03-20 CA CA3214270A patent/CA3214270A1/en active Pending
- 2022-03-20 WO PCT/US2022/021058 patent/WO2022198115A1/en not_active Ceased
- 2022-03-20 MX MX2023010978A patent/MX2023010978A/es unknown
- 2022-03-20 CA CA3214084A patent/CA3214084A1/en active Pending
- 2022-03-20 BR BR112023019077A patent/BR112023019077A2/pt unknown
- 2022-03-20 US US18/282,934 patent/US20240300894A1/en active Pending
- 2022-03-20 CA CA3214305A patent/CA3214305A1/en active Pending
- 2022-03-20 EP EP22772333.5A patent/EP4308545A4/en active Pending
- 2022-03-20 JP JP2023557288A patent/JP7897863B2/ja active Active
- 2022-03-20 CN CN202280034756.0A patent/CN117321031A/zh active Pending
- 2022-03-20 AU AU2022239618A patent/AU2022239618A1/en active Pending
- 2022-03-20 AU AU2022237675A patent/AU2022237675A1/en active Pending
- 2022-03-20 MX MX2023010976A patent/MX2023010976A/es unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5384330A (en) * | 1992-01-08 | 1995-01-24 | Asta Medica Aktiengesellschaft | Pharmaceutically active 1,2,4-triamino-benzene derivatives, processes for their preparation and pharmaceutical compositions containing them |
| US20060004197A1 (en) * | 2004-07-02 | 2006-01-05 | Thomas Thrash | Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| CN102159535A (zh) * | 2008-07-22 | 2011-08-17 | 特拉维夫大学拉莫特有限公司 | 钾离子通道调节剂及其用途 |
| CN103073455A (zh) * | 2011-10-25 | 2013-05-01 | 中国科学院上海药物研究所 | 一类新型的kcnq钾通道激动剂、其制备方法和用途 |
| WO2016077724A1 (en) * | 2014-11-13 | 2016-05-19 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | (2-amino-4(arylamino)phenyl) carbamates |
| CN109641836A (zh) * | 2016-06-10 | 2019-04-16 | 赛弗卢尔生命科学公司 | 氟化的2-氨基-4-(取代的氨基)苯基氨基甲酸酯衍生物 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU781064B2 (en) | Di-substituted iminoheterocyclic compounds | |
| IL263429B (en) | Crystalline forms of triazolopyrimidine compound | |
| KR102791742B1 (ko) | (s)-3-아미노-4-(디플루오로메틸레닐)사이클로펜트-1-엔-1-카르복실산의 합성을 위한 공정 | |
| CN103261199A (zh) | 萘啶衍生物 | |
| WO2019154252A1 (zh) | 取代的烟酰胺类化合物及药物组合物及其用途 | |
| WO2014010748A1 (en) | Cyclopropane derivative having bace1 inhibiting activity | |
| US20240208896A1 (en) | Prodrugs of kv7 channel openers | |
| TW201444786A (zh) | 雙環化合物 | |
| AU2009330131B2 (en) | Compounds and methods for the treatment of pain and other diseases | |
| TW202204343A (zh) | 經取代之３－苯氧基氮雜環丁烷－１－基－吡 | |
| US20120283274A1 (en) | Crystalline forms of substituted pyrazolopyrimidines | |
| JP2020073523A (ja) | 置換されたイミダゾピリジニル−アミノピリジン化合物の塩および多型 | |
| RU2352563C2 (ru) | Атропоизомеры производных 3-замещенного-4-арилхинолин-2-она | |
| US9505743B2 (en) | Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases | |
| WO2018135659A1 (ja) | 電位依存性ｔ型カルシウムチャネル阻害剤 | |
| JP4355144B2 (ja) | 新規含窒素環状化合物 | |
| AU637848B2 (en) | Pyridine-2,4- and 2,5-dicarboxamides, a process for the preparation thereof, and the use thereof | |
| WO2025180517A1 (zh) | 含sf5类喹啉衍生物及其作为p2x7拮抗剂的用途 | |
| KR20250117821A (ko) | Hdac 억제제 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |